The EFF is a growing multiple stakeholder platform for the exchange and sharing of insights and innovations to drive the future of clinical development in inherited retinal diseases. Organized by ProQR
… functions. Axiomer could potentially yield a new class of innovative medicines and treat currently untreatable … uncommon problems and critical about own work Passion for innovation and drive to deliver new therapies to patients …
… functions. Axiomer® could potentially yield a new class of innovative medicines and treat currently untreatable … forms are recognized and valued. We offer an exciting and innovative working environment in a very committed … recruitment@proqr.com if you have any questions. Science & Innovation …